Skip to content

Infertility treatment clinic Jindal IVF organizes 21st Continuing Medical Education event on Assisted Reproductive Technologies in Chandigarh, highlighting advancements in handling infertility cases.

Gathering of specialists, both experienced and new, to delve into latest advancements in assisted reproduction technology, dealing with male infertility, practices in IVF laboratories, and providing clinical workshops.

Jindal IVF organizes the 21st Continuing Medical Education (CME) on Assisted Reproductive...
Jindal IVF organizes the 21st Continuing Medical Education (CME) on Assisted Reproductive Technologies (ART) in Chandigarh, emphasizing advancements in infertility treatment.

Infertility treatment clinic Jindal IVF organizes 21st Continuing Medical Education event on Assisted Reproductive Technologies in Chandigarh, highlighting advancements in handling infertility cases.

In August 2025, the Indian pharma and healthcare sector faced a substantial decrease in funding, with a total of $47 million raised. This marked a significant drop of 82% compared to previous months, indicating a challenging period for the sector.

The funding shortage was not limited to one specific entity, as the total amount of funding for Indian pharma and healthcare in August 2025 fell to $47 million. This decline in financing was noteworthy, as it reached a record low for the sector.

Despite the funding challenges, the Indian pharma and healthcare sector continued to make strides in other areas. For instance, the Madras Dyslexia Association developed a toolkit named 'Count on Me', designed to support children.

Meanwhile, Aster DM Healthcare made a strategic move by acquiring an additional 13% stake in Aster Ramesh Hospitals. This acquisition is expected to bolster the company's presence in the Indian healthcare market.

However, no specific information from the search results indicates who reduced the financing of the Indian pharmaceutical and healthcare sector from 82% to $47 million. This remains a question for further investigation.

In conclusion, the Indian pharma and healthcare sector experienced a significant drop in funding in August 2025, reaching a record low of $47 million. Despite this, the sector continues to innovate and adapt, with initiatives like the 'Count on Me' toolkit and strategic acquisitions like Aster DM Healthcare's stake in Aster Ramesh Hospitals.

Read also: